ARWR - Company ID 0000879407
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) reported net income of -$1.63M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$1.63M | +99.7% |
| FY 2024 | -$599.49M | -192.0% |
| FY 2023 | -$205.28M | -16.6% |
| FY 2022 | -$176.06M | -25.0% |
| FY 2021 | -$140.85M | -66.6% |
| FY 2020 | -$84.55M | -224.4% |
| FY 2019 | $67.97M | +224.8% |
| FY 2018 | -$54.45M | -58.4% |
| FY 2017 |
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) reported net income of -$1.63M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, ARROWHEAD PHARMACEUTICALS, INC.'s net income grew from -$3.13M to -$1.63M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| -$34.38M |
| +57.9% |
| FY 2016 | -$81.72M | +11.1% |
| FY 2015 | -$91.94M | -56.8% |
| FY 2014 | -$58.63M | -88.3% |
| FY 2013 | -$31.14M | -47.4% |
| FY 2012 | -$21.13M | -575.2% |
| FY 2011 | -$3.13M | - |